SGTX - Sigilon Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Sigilon Therapeutics's activity chart (see below) currently has 11 price targets and 12 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.33% with an average time for these price targets to be met of 139.5 days.

Most recent stock forecast was given by WHITNEY IJEM from CANACCORD on 05-Jul-2023. First documented stock forecast 29-Dec-2020.

Best performing analysts who are covering SGTX - Sigilon Therapeutics:

Thomas Shrader Matthew Harrison Gena Wang Michelle Gilson Whitney Ijem Dennis Ding

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Jan-2023

$30

$7.53 (33.51%)

$6

3 years 3 months 26 days ago
(05-Jul-2023)

1/2 (50%)

$8.45 (39.21%)

127

Hold Since 30-Nov-2021

$21

$-1.47 (-6.54%)

$58.5

3 years 4 months 1 days ago
(30-Jun-2023)

1/2 (50%)

$-1.51 (-6.71%)

26

Buy Since 28-Oct-2021

$14

3 years 4 months 1 days ago
(30-Jun-2023)

2/2 (100%)

$-50.35 (-78.24%)

173

Buy Since 24-Dec-2021

$7

$-15.47 (-68.85%)

$91

4 years 10 months 3 days ago
(28-Dec-2021)

1/2 (50%)

$-28.1 (-80.06%)

268

Buy Since 29-Dec-2020

$91

$68.53 (304.98%)

$208

4 years 10 months 29 days ago
(02-Dec-2021)

1/3 (33.33%)

$50.7 (125.81%)

2

Show more analysts

Please expand the browser size to see the chart

What is SGTX (Sigilon Therapeutics) average time for price targets to be met?

On average it took 140 days for the stock forecasts to be reached, with an average price target met ratio of 63.33%.

Which analyst most recently updated their price target on SGTX (Sigilon Therapeutics)?

Whitney Ijem

Which analyst has the most public recommendations on SGTX (Sigilon Therapeutics)?

Whitney Ijem works at CANACCORD and has 11 price targets and 7 ratings on SGTX

Which analyst is the currently most bullish on SGTX (Sigilon Therapeutics)?

Gena Wang with the highest potential upside of $68.53

Which analyst is the currently most reserved on SGTX (Sigilon Therapeutics)?

Michelle Gilson with the lowest potential downside of -$15.47
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?